Objective: To evaluate the effectiveness of intramuscular neurolysis with alcohol for the treatment of finger fiexor spasticity in individuals with stroke.
Design: Case series.
Setting: Outpatient clinic of a tertiary rehabilitation facility.
Subjects: Thirty patients with a mean age of 60.2 years and post-stroke duration of 8.3 months with finger fiexor spasticity.
Interventions: Intramuscular neurolysis or motor point blocks of the finger fiexors of the hemiplegic upper extremity with 50% ethyl alcohol.
Main outcome measures: The severity of spasticity as measured by the Modified Ashworth Scale (MAS) and the passive range of motion of the proximal interphalangeal joints of the second to fifth digits.
Results: The mean baseline MAS score was 4.0 ± 0.5 and this improved to 2.0 ± 0.6, 2.2 ± 0.6 and 2.6 ± 0.6 at four weeks, three months and six months post neurolysis respectively. The gains in range of motion were 18.5 ± 6.7, 17.5 ± 6.4 and 14.9 ± 4.8 degrees at four weeks, three months and six months post neurolysis respectively. These improvements were statistically significant (p < 0.05). Two subjects developed temporary dysesthetic pain of the forearm and palm.
Conclusion: Intramuscular neurolysis with alcohol provides good relief of finger fiexor spasticity in hemiplegic individuals.
Get full access to this article
View all access options for this article.
References
1.
Glenn MB. Nerve blocks. In: Glenn MB, Whyte J eds. The practical management of spasticity in children and adults. Philadelphia: Lea & Febiger, 1990: 227–258.
Bohannon RW, Smith MB. Interrater reliability of the Modified Ashworth Scale of muscle spasticity. Phys Ther1986; 67: 206–207.
4.
Tardieu G, Tardieu C, Hariga J, Gagnard L. Treatment of spasticity by injection of dilute alcohol at the motor point or by epidural route. Dev Med Child Neurol1968; 10: 555–568.
5.
Carpenter EB, Seitz DG. Intramuscular alcohol as an aid in the management of spastic cerebral palsy. Dev Med Child Neurol1980; 22: 497–501.
6.
Brazeau GA, Fung HL. Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro–in vivo correlation and predictability with mixed solvent systems. Pharm Res1989; 6: 766–771.
